The study, published in the Journal of Clinical Oncology, examined national statistics for the period between 2007 to 2010 for people aged 18-64 of age.
A new U.S. study finds that cancer patients who don't have insurance -- or who get it through the federal health insurance program for the poor (Medicaid) -- are at much higher risk of poor medical outcomes than other people.
They're more likely to have advanced cancer when they're diagnosed, less likely to be treated with surgery or radiation and more likely to die of their disease, researchers report.
The findings don't explain the discrepancies, and they don't say anything about how health care reform might change the fates of poor patients with cancer. Still, they offer a worrisome picture of the American health care system in the years right before the Affordable Care Act, or Obamacare, as some call it, was passed.
"We were surprised to find that patients without insurance were twice as likely as those with insurance to present with cancer that's spread from the place where it first started," said study author Dr. Gary Walker, a radiation oncologist at the University of Texas MD Anderson Cancer in Houston. "Even when adjusting for many different factors, patients were still more likely to die if they had Medicaid coverage or no insurance."
Original report: http://bit.ly/Vg6kVD
Source: US News
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen